AIN457 in patients with psoriatic arthritis

• Research type

  Research Study

• Full title

  Randomized , double-blind placebo-controlled multi-center proof-of-concept study to assess the efficacy of AIN457 in patients with psoriatic arthritis

• IRAS ID

  7164

• Sponsor organisation

  Novartis Pharmaceuticals

• Eudract number

  2008-002628-27

• ISRCTN Number

  N/A

• Research summary

  The study is designed to show the Effectiveness of AIN457, after 6 weeks of use, in patients with psoriatic arthritis. Effectiveness is measured using the ACriscoring system. The ACriscore comprises of a patientsrating of their own pain and physicians rating of joint tenderness and swelling, patient and physician rating of disease activity and two biological tests.

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  08/H1208/46

• Date of REC Opinion

  15 Jan 2009

• REC opinion

  Further Information Favourable Opinion